Each week we highlight five things affecting the life sciences industry. Here's the latest. Public biotech financings on pace for best quarter since 2021 According to Biopharma Dive, publicly traded biotech companies have raised nearly $10 billion in follow-on stock offerings during the first ... READ MORE >
Health care
5 things to know in life sciences: Week of March 4, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biden administration receives counteroffers from drug companies The Biden administration has received counteroffers from drug manufacturers in Medicare price negotiations under the Inflation Reduction Act, ... READ MORE >
5 things to know in life sciences: Week of Feb. 26, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. 3D bioprinting: New era in regenerative medicine Recent advancements in 3D bioprinting, including the development of functional human brain tissue and replacement tissue for treating injured cartilage, signal ... READ MORE >
5 things to know in life sciences: Week of Feb. 19, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA warns against fraudulent data in medical device premarket submissions The U.S. Food and Drug Administration is alerting medical device manufacturers about the rise in fraudulent and unreliable laboratory ... READ MORE >
5 things to know in life sciences: Week of Feb. 12, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Global health care’s push for climate resilience Following NHS England's 2020 commitment to net zero emissions by 2045, over 20 countries are adopting similar goals, aiming to create climate-resilient health ... READ MORE >
5 things to know in life sciences: Week of Feb. 5, 2024
This week we highlight the acquisition of a contract manufacturing organization to meet the high demand for GLP-1s, the funding of Australian medtech startups, and a shift in pharma from large deals to smaller acquisitions. We also examine the investment into the psychedelic medicine industry. ... READ MORE >
5 things to know in life sciences: Week of Jan. 29, 2024
This week we highlight the beginning of the first round of Inflation Reduction Act drug negotiations, the increasing popularity of co-working spaces in the biotech industry, and the mergers and acquisitions outlook in the area of central nervous system disorders. We also examine a U.S. Food and Drug ... READ MORE >
Preparing for new cybersecurity rules: Considerations for NY hospitals
In an effort to address cybersecurity threats in hospitals in New York, the state Department of Health proposed a new rule in December aimed at safeguarding hospital systems and nonpublic information. The proposed regulation, which is open for public comment until Feb. 5, would require hospitals to ... READ MORE >
5 things to know in life sciences: Week of Jan. 22, 2024
This week we highlight the early 2024 surge in biotech initial public offerings, a potential TikTok campaign to boost vaccine uptake and proposals relating to extending the transition of European medtech regulations. We also examine the U.S. Food and Drug Administration’s warnings of potential cancer ... READ MORE >
5 things to know in life sciences: Week of Jan. 15, 2024
This week we highlight potential new medtech regulations in the UK, challenges facing CAR-T therapies and another CRISPR-based gene therapy approval. We also examine the multi-faceted approach being taken by biotech companies seeking funding or potential exits. Additionally, we look at a new device for ... READ MORE >